Social-cognitive correlates of CPAP adherence in experienced users

Sleep Medicine

Volumn 7, Issue 4, 2006, Pages 350-356

  Stepnowsky, Carl J ^a,b   Marler, Matthew R ^b   Palau, Joe ^a   Annette Brooks, J ^c  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

Author keywords

Continuous positive airway pressure; Models, psychological; Patient compliance; Self efficacy; Sleep apnea syndromes

Indexed keywords

ADULT; AGED; ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; POSITIVE END EXPIRATORY PRESSURE; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SLEEP APNEA SYNDROME; SOCIAL ASPECT; SOCIAL COGNITIVE THEORY; STATISTICAL SIGNIFICANCE; SYMPTOM; VALIDATION PROCESS;

BODY MASS INDEX; COGNITION; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUESTIONNAIRES; SLEEP APNEA, OBSTRUCTIVE; SOCIAL BEHAVIOR;

EID: 33646918830     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sleep.2005.11.004     Document Type: Article

References (46)

1. Bassiri A.G., and Guilleminault C. Clinical features and evaluation of obstructive sleep apnea-hypopnea syndrome. In: Dement W.C. (Ed). Principle and practice of sleep medicine (2000), Saunders, Philadelphia, PA 869-878
2. Young T., Peppard P., Palta M., et al. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157 15 (1997) 1746-1752
3. Young T., Blustein J., Finn L., and Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 20 8 (1997) 608-613
4. He J., Kryger M.H., Zorick F.J., et al. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94 1 (1988) 9-14
5. Partinen M., Jamieson A., and Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortal Chest 94 6 (1988) 1200-1204
6. Chobanian A.V., Bakris G.L., Black H.R., et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. J Am Med Assoc 289 19 (2003) 2560-2572
7. Sullivan C.E., Issa F.G., Berthon-Jones M., and Eves L. Reversal of obstructive sleep apnoea by continuous positive airway pressure applied through the nares. Lancet 1 8225 (1981) 862-865
8. Loube D.I., Gay P.C., Strohl K.P., et al. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: a consensus statement. Chest 115 3 (1999) 863-866
9. Patel S.R., White D.P., Malhotra A., et al. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 163 5 (2003) 565-571
10. Wright J., Johns R., Watt I., et al. Health effects of obstructive sleep apnoea and the effectiveness of continuous positive airways pressure: a systematic review of the research evidence. B Med J 314 7084 (1997) 851-860
11. McArdle N., and Douglas N.J. Effect of continuous positive airway pressure on sleep architecture in the sleep apnea-hypopnea syndrome: a randomized controlled trial. Am J Respir Crit Care Med 164 8 Pt 1 (2001) 1459-1463
12. Pepperell J.C., Ramdassingh-Dow S., Crosthwaite N., et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 359 9302 (2002) 204-210
13. Bahammam A.S., Delaive K., Ronald J., et al. Health care utilization in males with obstructive sleep apnea syndrom two years after diagnosis and treatment. Sleep 22 (1999) 740-747
14. Kribbs N.B., Pack A.I., Kline L.R., et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis 147 4 (1993) 887-895
15. Reeves-Hoche M.K., Meck R., and Zwillich C.W. Nasal CPAP: an objective evaluation of patient compliance. Am J Respir Crit Care Med 149 1 (1994) 149-154
16. Stepnowsky C., Marler M.R., and Ancoli-Israel S. Determinants of nasal CPAP compliance. Sleep Med 3 3 (2002) 239-247
17. Collard P., Pieters T., Aubert G., et al. Compliance with nasal CPAP in obstructive sleep apnea patients. Sleep Med Rev 1 (1997) 33-44
18. Engleman H.M., and Wild M.R. Improving CPAP use by patients with the sleep apnoea/hypopnoea syndrome (SAHS). Sleep Med Rev 7 1 (2003) 81-99
19. Kingshott R.N., Vennelle M., Hoy C.J., et al. Predictors of improvements in daytime function outcomes with CPAP therapy. Am J Respir Crit Care Med 161 3 Pt 1 (2000) 866-871
20. Pelletier-Fleury N., Rakotonanahary D., and Fleury B. The age of other factors in the evaluation of compliance with nasal continuous positive airway pressure for obstructive sleep apnea syndrome: a cox's proportional hazard analysis. Sleep Med 2 (2001) 225-232
21. Wild M.R., Engleman H.M., Douglas N.J., and Espie C.A. Can psychological factors help us to determine adherence to CPAP? A prospective study. Eur Respir J 24 3 (2004) 461-465
22. Bandura A. Social foundations of thought and action. A social cognitive theory (1986), Prentice Hall, Englewood Cliffs, NJ
23. Prochaska J.O., Redding C.A., and Evers K.E. The transtheoreticl model and stages of change. In: Glanz K., Lewis F.M., and Rimer B.K. (Eds). Health behavior and health education (1997), Josey-Bass Publishers, San Francisco, CA
24. Edinger J.D., Carwile S., Miller P., and Mayti C. Psychological status, syndromatic measures, and compliance with nasal CPAP therapy for sleep apnoea. Percept Mot Skills 78 (1994) 1116-1118
25. Hui D.S., Choy D.K., Li T.S., et al. Determinants of continuous positive airway pressure compliance in a group of Chinese patients with obstructive sleep apnea. Chest 120 1 (2001) 170-176
26. Rauscher H., Formanek D., Popp W., and Zwick H. Self-reported vs measured compliance with nasal CPAP for obstructive sleep apnea. Chest 103 6 (1993) 1675-1680
27. Hoy C.J., Vennelle M., Kingshott R.N., et al. Can intensive support improve continuous positive airway pressure use in patients with the sleep apnea/hypopnea syndrome?. Am J Respir Crit Care Med 159 4 Pt 1 (1999) 1096-1100
28. Likar L., Panciera T., Erickson A., and Rounds S. Group education sessions and compliance with nasal CPAP therapy. Chest 111 5 (1997) 1273-1277
29. Hui D.S., Chan J.K., Choy D.K., et al. Effects of augmented continuous positive airway pressure education and support on compliance and outcome in a Chinese population. Chest 117 5 (2000) 1410-1416
30. Aloia M.S., Arnedt J.T., Riggs R.L., et al. Clinical management of poor adherence to CPAP: motivational enhancement. Behav Sleep Med 2 4 (2004) 205-222
31. Aloia M.S., Di Dio L., Ilniczky N., et al. Improving compliance with nasal CPAP and vigilance in older adults with OAHS. Sleep Breath 5 1 (2001) 13-21
32. Stepnowsky Jr. C.J., and Moore P.J. Nasal CPAP treatment for obstructive sleep apnea: developing a new perspective on dosing strategies and compliance. J Psychosom Res 54 6 (2003) 599-605
33. Kryger M. Management of obstructive sleep apnea-hypopnea syndrom: overview. In: Dement W.C. (Ed). Principles and practice of sleep medicine (2000), Saunders, Philadelphia, PA 940-954
34. Kribbs N.B., Pack A.I., Kline L.R., et al. Effects of one night without nasal CPAP treatment on sleep and sleepiness in patients with obstructive sleep apnea. Am Rev Respir Dis 147 5 (1993) 1162-1168
35. Sforza E., and Lugaresi E. Daytime sleepiness and nasal continuous positive airway pressure therapy in obstructive sleep apnea syndrome patients: effects of chronic treatment and 1-night therapy withdrawal. Sleep 18 3 (1995) 195-201
36. Collop N.A., Block A.J., and Hellard D. The effect of nightly nasal CPAP treatment on underlying obstructive sleep apnea and pharyngeal size. Chest 99 4 (1991) 855-860
37. Hers V., Liistro G., Dury M., et al. Residual effect of nCPAP applied for part of the night in patients with obstructive sleep apnoea. Eur Respir J 10 5 (1997) 973-976
38. Stepnowsky C., and Dimsdale J. Dose-response relationship between CPAP compliance and measures of sleep apnea severity. Sleep Med 3 (2002) 329-334
39. Engleman H.M., Martin S.E., Deary I.J., and Douglas N.J. Effect of continuous positive airway pressure treatment on daytime function in sleep apnoea/hypopnoea syndrome. Lancet 343 8897 (1994) 572-575
40. Engleman H.M., Martin S.E., Deary I.J., and Douglas N.J. Effect of CPAP therapy on daytime function in patients with mild sleep apnoea/hypopnoea syndrome. Thorax 52 2 (1997) 114-119
41. Stradling J.R., and Davies R.J. Is more NCPAP better?. Sleep 23 Suppl. 4 (2000) S150-S153
42. Zozula R., and Rosen R. Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med 7 6 (2001) 391-398
43. Gifford A.L., and Groessl E.J. Chronic disease self-management and adherence to HIV medications. J Acq Immu Def Syn 31 Suppl. 3 (2002) S163-S166
44. Lorig K.R., and Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med 26 1 (2003) 1-7
45. Lorig K.R., Ritter P., Stewart A.L., et al. Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care 39 11 (2001) 1217-1223
46. Von Korff M., Moore J.E., Lorig K., et al. A randomized trial of a lay person-led self-management group intervention for back pain patients in primary care. Spine 23 23 (1998) 2608-2615